Cancer Treatment Drugs are drugs that fight cancer. At present, there are about 130 to 150 anticancer drugs approved by the countries in the world. There are about 1300 to 1500 kinds of various anticancer drug preparations prepared by these drugs. In the anticancer drugs, they are divided into two major categories: western medicine and traditional Chinese medicine according to their different treatment characteristics. Western medicine includes chemotherapy and biological targeted therapeutic drugs, while traditional Chinese medicines include prescription drugs and proprietary Chinese medicines that are commonly used in clinical practice.
The report focuses on the Cancer Treatment Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Cancer Treatment Drugs market.
Major Players in the Cancer Treatment Drugs market are:
Kyowa Hakko Kirin
Takeda
Gilead Sciences
Bayer
Teva
Eli Lilly
AbbVie
Roche
Otsuka
Johnson & Johnson
Celgene
Eisai
Astellas
Bristol-Myers Squibb
AstraZeneca
Amgen
Merck & Co.
Ipsen
Novartis
Merck KGaA
Biogen Idec
Sanofi
Pfizer
On the basis of types, the Cancer Treatment Drugs market is primarily split into:
Hormonal Therapy
Immunotherapy (Biologic Therapy)
Targeted Therapy
Chemotherapy
Others
On the basis of applications, the market covers:
Patient Organization
Hospital
Government Organization
Volunteer Organization
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Cancer Treatment Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Cancer Treatment Drugs Market Overview
1.1 Product Overview and Scope of Cancer Treatment Drugs Market
1.2 Cancer Treatment Drugs Market Segment by Type
1.2.1 Global Cancer Treatment Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Cancer Treatment Drugs Market Segment by Application
1.3.1 Cancer Treatment Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Cancer Treatment Drugs Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Cancer Treatment Drugs (2017-2029)
1.5.1 Global Cancer Treatment Drugs Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Cancer Treatment Drugs Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Cancer Treatment Drugs Industry
1.7 Impact of Carbon Neutrality on the Cancer Treatment Drugs Industry
2 Cancer Treatment Drugs Market Upstream and Downstream Analysis
2.1 Cancer Treatment Drugs Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Cancer Treatment Drugs Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Kyowa Hakko Kirin
3.1.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Takeda
3.2.1 Takeda Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Gilead Sciences
3.3.1 Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Bayer
3.4.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Teva
3.5.1 Teva Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Eli Lilly
3.6.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.6.4 Business Overview
3.7 AbbVie
3.7.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Roche
3.8.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Otsuka
3.9.1 Otsuka Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Johnson & Johnson
3.10.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Celgene
3.11.1 Celgene Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Eisai
3.12.1 Eisai Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Astellas
3.13.1 Astellas Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Bristol-Myers Squibb
3.14.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.14.4 Business Overview
3.15 AstraZeneca
3.15.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.15.4 Business Overview
3.16 Amgen
3.16.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.16.4 Business Overview
3.17 Merck & Co.
3.17.1 Merck & Co. Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Ipsen
3.18.1 Ipsen Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.18.4 Business Overview
3.19 Novartis
3.19.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.19.4 Business Overview
3.20 Merck KGaA
3.20.1 Merck KGaA Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Product Profiles, Application and Specification
3.20.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.20.4 Business Overview
3.21 Biogen Idec
3.21.1 Biogen Idec Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Product Profiles, Application and Specification
3.21.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.21.4 Business Overview
3.22 Sanofi
3.22.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Product Profiles, Application and Specification
3.22.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.22.4 Business Overview
3.23 Pfizer
3.23.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.23.2 Product Profiles, Application and Specification
3.23.3 Cancer Treatment Drugs Market Performance (2017-2022)
3.23.4 Business Overview
4 Global Cancer Treatment Drugs Market Landscape by Player
4.1 Global Cancer Treatment Drugs Sales and Share by Player (2017-2022)
4.2 Global Cancer Treatment Drugs Revenue and Market Share by Player (2017-2022)
4.3 Global Cancer Treatment Drugs Average Price by Player (2017-2022)
4.4 Global Cancer Treatment Drugs Gross Margin by Player (2017-2022)
4.5 Cancer Treatment Drugs Market Competitive Situation and Trends
4.5.1 Cancer Treatment Drugs Market Concentration Rate
4.5.2 Cancer Treatment Drugs Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Cancer Treatment Drugs Sales, Revenue, Price Trend by Type
5.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2017-2022)
5.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Cancer Treatment Drugs Price by Type (2017-2022)
5.4 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate of Hormonal Therapy (2017-2022)
5.4.2 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate of Immunotherapy (Biologic Therapy) (2017-2022)
5.4.3 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate of Targeted Therapy (2017-2022)
5.4.4 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate of Chemotherapy (2017-2022)
5.4.5 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate of Others (2017-2022)
6 Global Cancer Treatment Drugs Market Analysis by Application
6.1 Global Cancer Treatment Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Cancer Treatment Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Cancer Treatment Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Cancer Treatment Drugs Consumption and Growth Rate of Patient Organization (2017-2022)
6.3.2 Global Cancer Treatment Drugs Consumption and Growth Rate of Hospital (2017-2022)
6.3.3 Global Cancer Treatment Drugs Consumption and Growth Rate of Government Organization (2017-2022)
6.3.4 Global Cancer Treatment Drugs Consumption and Growth Rate of Volunteer Organization (2017-2022)
7 Global Cancer Treatment Drugs Sales and Revenue Region Wise (2017-2022)
7.1 Global Cancer Treatment Drugs Sales and Market Share, Region Wise (2017-2022)
7.2 Global Cancer Treatment Drugs Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Cancer Treatment Drugs Market Forecast (2022-2029)
8.1 Global Cancer Treatment Drugs Sales, Revenue Forecast (2022-2029)
8.1.1 Global Cancer Treatment Drugs Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Cancer Treatment Drugs Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Cancer Treatment Drugs Price and Trend Forecast (2022-2029)
8.2 Global Cancer Treatment Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Cancer Treatment Drugs Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Cancer Treatment Drugs Sales and Revenue Forecast (2022-2029)
8.2.3 China Cancer Treatment Drugs Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Cancer Treatment Drugs Sales and Revenue Forecast (2022-2029)
8.2.5 India Cancer Treatment Drugs Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Cancer Treatment Drugs Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Cancer Treatment Drugs Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Cancer Treatment Drugs Sales and Revenue Forecast (2022-2029)
8.3 Global Cancer Treatment Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Cancer Treatment Drugs Revenue and Growth Rate of Hormonal Therapy (2022-2029)
8.3.2 Global Cancer Treatment Drugs Revenue and Growth Rate of Immunotherapy (Biologic Therapy) (2022-2029)
8.3.3 Global Cancer Treatment Drugs Revenue and Growth Rate of Targeted Therapy (2022-2029)
8.3.4 Global Cancer Treatment Drugs Revenue and Growth Rate of Chemotherapy (2022-2029)
8.3.5 Global Cancer Treatment Drugs Revenue and Growth Rate of Others (2022-2029)
8.4 Global Cancer Treatment Drugs Consumption Forecast by Application (2022-2029)
8.4.1 Global Cancer Treatment Drugs Consumption Value and Growth Rate of Patient Organization (2022-2029)
8.4.2 Global Cancer Treatment Drugs Consumption Value and Growth Rate of Hospital (2022-2029)
8.4.3 Global Cancer Treatment Drugs Consumption Value and Growth Rate of Government Organization (2022-2029)
8.4.4 Global Cancer Treatment Drugs Consumption Value and Growth Rate of Volunteer Organization (2022-2029)
8.5 Cancer Treatment Drugs Market Forecast Under COVID-19
9 Industry Outlook
9.1 Cancer Treatment Drugs Market Drivers Analysis
9.2 Cancer Treatment Drugs Market Restraints and Challenges
9.3 Cancer Treatment Drugs Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Cancer Treatment Drugs Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Cancer Treatment Drugs Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Cancer Treatment Drugs Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global 5-Fluorouracil Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 76
The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030.
North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
Global Carboplatin Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
Global Neutropenia Drugs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 96
The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
Global Small Molecule Cancer Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
Global Capecitabine Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 80
Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
Global Oxaliplatin Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely.
In this report, only The finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
Global Cancer Treatment Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
Global Capecitabine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period.
The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Methotrexate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
